| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1111/J.1749-6632.1989.TB27365.X |
| P698 | PubMed publication ID | 2698084 |
| P2093 | author name string | Mekalanos JJ | |
| Miller SI | |||
| P2860 | cites work | Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I | Q24651553 |
| A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. | Q34286908 | ||
| Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin | Q34618561 | ||
| Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli | Q34633814 | ||
| Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent | Q35617117 | ||
| Mechanisms of acquired resistance in mouse typhoid | Q36268345 | ||
| The route of enteric infection in normal mice | Q36273394 | ||
| Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans | Q36355455 | ||
| Covalent modification of the glnG product, NRI, by the glnL product, NRII, regulates the transcription of the glnALG operon in Escherichia coli | Q37394494 | ||
| TnphoA: a transposon probe for protein export signals | Q37557281 | ||
| Development of an auxotrophic oral live Shigella flexneri vaccine | Q39227963 | ||
| Safe, live Vibrio cholerae vaccines? | Q39468623 | ||
| Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines | Q39513114 | ||
| Auxotrophic Salmonella typhi as live vaccine | Q39649722 | ||
| Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions | Q40791588 | ||
| Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report | Q40792921 | ||
| Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation | Q40797037 | ||
| Safety and Antigenicity of Typhoid-Shigella sonnei Vaccine (Strain 5076-1C) | Q40829610 | ||
| Vi serology in detection of chronic Salmonella typhi carriers in an endemic area | Q40834194 | ||
| Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine | Q40897058 | ||
| A seven-year field trial of two typhoid vaccines in Guyana | Q40951452 | ||
| Positive control of a regulon for defenses against oxidative stress and some heat-shock proteins in Salmonella typhimurium | Q41771946 | ||
| Conserved domains in bacterial regulatory proteins that respond to environmental stimuli | Q45012102 | ||
| Incidence of salmonellosis in patients with AIDS. | Q46234179 | ||
| Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine | Q48245954 | ||
| Nucleotide sequence of the phoR gene, a regulatory gene for the phosphate regulon of Escherichia coli | Q48354987 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cholera | Q12090 |
| typhoid fever | Q83319 | ||
| shigellosis | Q327298 | ||
| P304 | page(s) | 145-154 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Strategies for the development of vaccines for typhoid fever, shigellosis, and cholera | |
| P478 | volume | 569 |
| Q40375337 | Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression | cites work | P2860 |
Search more.